BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

WuXi XDC and LCB Signed MOU for the Development and Manufacturing of Antibody-drug Conjugates

Under the partnership, LCB will have access to XDC' integrated services in mAb, linker, payload, analytical and formulation development as well as ADC drug...

June 10, 2021 | News

iResearch Atlanta welcomes new investigators and expands its operations

iResearch Atlanta welcomes new investigators and expands its operations to serve more patients in phase I-IV clinical trials, the ability to cont...

June 10, 2021 | News

21% were not aware Australian data is accepted by the FDA and other major regulatory authorities

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results o...

June 04, 2021 | Analysis

Akoya launches Advanced Biopharma Solutions

Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced the launch of Advanced Biopharma Solutions (ABS) as a premium serv...

June 03, 2021 | News

Novartis provides update on BEOVU clinical program

Novartis has also decided on early termination of the RAPTOR and RAVEN studies, which assessed the efficacy and safety of brolucizumab in retinal vein occl...

May 30, 2021 | News

Avance Clinical Releases Industry Survey Results at BIO Korea 2021

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a rec...

May 27, 2021 | News

PPD Opens Multipurpose Clinical Research Laboratory in China

PPD, Inc. (Nasdaq:PPD), a leading global contract research organization, is opening a new laboratory in Suzhou, China, to support China-base...

May 26, 2021 | News

Boehringer Ingelheim's Receives FDA Breakthrough for CONNEX trial program

BI 425809, A Novel Glycine transporter-1 (GlyT1) Inhibitor To Be Studied in First-of-its-Kind Phase III Trials, Incorporating Speech Analytics and Virtual ...

May 25, 2021 | News

Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity

Call for application for the seventh global crowdsourcing project with Merck, ‘Regulatory T Cell Dysfunction in Autoimmunity and Inflammaging&rsquo...

May 17, 2021 | News

Merck’s Focus on Cancer

Merck Highlights Scientific Data at 2021 ASCO Annual Meeting Across More Than 20 Cancer Types From Broad Oncology Research Program Merck (NYSE: MR...

May 13, 2021 | News

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier...

May 12, 2021 | News

Stay Connected